Skip to content

Latest Updates

Home / Latest Updates

Latest Updates

New Publication: Increase in the Expression of Glucose Transporter 2 on the Peripheral Blood Insulin-Producing Cells in Type 1 Diabetic Patients After Receiving Stem Cell Educator Therapy

We are pleased to announce that Dr. Yong Zhao and his team published a new clinical research manuscript in the International Journal of Molecular Sciences (ijms), titled “Increase in the

Throne Welcomes Renowned Ophthalmologist, Dr. Robin Ross, as Director of Ophthalmology

Here at Throne Biotechnologies, we are pleased to announce Dr. Robin Ross, M.D., MPH, CPH as our Director of Ophthalmology. Dr. Ross is the Board Certified American Board of Ophthalmology

Throne Received FDA Approval on Regenerative Medicine Advanced Therapy (RMAT) Designation by Using Stem Cell Educator Therapy to Treat Type 1 Diabetes

Paramus, New Jersey (April 24, 2024) - Throne Biotechnologies is one of the global-leading biotech companies aiming to find a cure for type 1 diabetes. We are excited to announce

New Pre-Clinical Studies Demonstrate Cord Blood Stem Cells (CB-SC) Ameliorate the Graft-vs-Host Disease (GvHD) Involved in the Allogeneic Hematopoietic Stem Cell Transplantation

We are pleased to announce that Dr. Yong Zhao collaborated with his colleagues Dr. Robert Korngold’s group at the Center For Discovery and Innovation (CDI) of Hackensack Meridian Health, published

New Studies Revealed the New Molecular Mechanisms Underlying Stem Cell Educator Therapy on Human B Cells

We are happy to announce that Dr. Yong Zhao and his team published a new manuscript that revealed the new molecular mechanisms underlying Stem Cell Educator therapy for the treatment

Holiday Greetings: Happy New Year

Over the last year, Throne has made significant progresses in the FDA-approved clinical trials of Stem Cell Educator therapy for the treatment of type 1 diabetes (T1D), alopecia areata (AA)

Dr. Yong Zhao is invited as Guest Editor for the journal Biomedicines

We are pleased to announce that Dr. Yong Zhao, founder and CEO of Throne Biotechnologies, is invited by an academic journal Biomedicines to edit Special Issue, “Mitochondria in Human Health

Throne Welcomes Renowned Pediatrician, Dr. Richard Fox, as Pediatric Medical Director

Here at Throne Biotechnologies, we are pleased to announce Dr. Richard Fox, M.D., as our Pediatric Medical Director. Dr. Fox received his medical degree from the University of Minnesota in 1975